Imagen de Portada
Código QR

Evaluating Risk-Based Specifications for Pharmaceuticals.

Publicado en:Pharmaceutical Technology Vol. 37; no. 7; pp. 54 - 61
Autor principal: Burgess, Christopher
Formato: Journal Article
Publicado: MJH Life Sciences Jul2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107958092&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107958092
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15432521
        4FK
      jtl: Pharmaceutical Technology
      issn: 15432521
      maglogo: N
    pubinfo:
      dt: Jul2013
      vid: 37
      iid: 7
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        107958092
        2012186945
        107958092
      ppf: 54
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Evaluating Risk-Based Specifications for Pharmaceuticals.
      aug:
        au: Burgess, Christopher
        affil: Managing director, Burgess Analytical Consultancy Limited; Member, USP Council of Experts; Chairman, ECA Analytical Quality Control Group; Visiting professor, University of Strathclyde's School of Pharmacy and Biomedical Sciences
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N